Home/Filings/4/0001628280-25-054056
4//SEC Filing

Dimopoulos Christos 4

Accession 0001628280-25-054056

CIK 0001996862other

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 7:59 PM ET

Size

10.5 KB

Accession

0001628280-25-054056

Insider Transaction Report

Form 4
Period: 2025-11-21
Dimopoulos Christos
Co-President, Agribusiness
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-21$50.07/sh+5,300$265,371129,836.808 total
  • Exercise/Conversion

    Stock Options (Right to buy)

    2025-11-215,3000 total
    Exercise: $50.07Exp: 2026-03-01Common Stock (5,300 underlying)
  • Sale

    Common Stock

    2025-11-21$94.38/sh5,300$500,226124,536.808 total
  • Sale

    Common Stock

    2025-11-21$94.37/sh20,000$1,887,418104,536.808 total
Footnotes (3)
  • [F1]This transaction was executed in multiple trades at prices ranging from $94.30 to $94.48. The price reported reflects the weighted average sale price. The reporting person undertakes to provide to Bunge Global SA, any security holder of Bunge Global SA, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.
  • [F2]This transaction was executed in multiple trades at prices ranging from $94.28 to $94.44. The price reported reflects the weighted average sale price. The reporting person undertakes to provide to Bunge Global SA, any security holder of Bunge Global SA, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.
  • [F3]This option became exercisable in three equal annual installments beginning on March 1, 2017.

Issuer

Bunge Global SA

CIK 0001996862

Entity typeother

Related Parties

1
  • filerCIK 0001758115

Filing Metadata

Form type
4
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 7:59 PM ET
Size
10.5 KB